Abstract

Although various types of organs-on-chips have been introduced recently as tools for drug discovery, the current studies are limited in terms of fabrication methods. The fabrication methods currently available not only need a secondary cell-seeding process and result in severe protein absorption due to the material used, but also have difficulties in providing various cell types and extracellular matrix (ECM) environments for spatial heterogeneity in the organs-on-chips. Therefore, in this research, we introduce a novel 3D bioprinting method for organ-on-a-chip applications. With our novel 3D bioprinting method, it was possible to prepare an organ-on-a-chip in a simple one-step fabrication process. Furthermore, protein absorption on the printed platform was very low, which will lead to accurate measurement of metabolism and drug sensitivity. Moreover, heterotypic cell types and biomaterials were successfully used and positioned at the desired position for various organ-on-a-chip applications, which will promote full mimicry of the natural conditions of the organs. The liver organ was selected for the evaluation of the developed method, and liver function was shown to be significantly enhanced on the liver-on-a-chip, which was prepared by 3D bioprinting. Consequently, the results demonstrate that the suggested 3D bioprinting method is easier and more versatile for production of organs-on-chips.

Highlights

  • In recent decades, the microfluidics-based cell culture platform has been revealed as an effective experimental tool for a wide range of biological applications, such as metabolomics,[1] cell analysis,[2,3] and organs-on-chips.[4]

  • It is generally known that the current 2D in vitro cell culture model, with cells only, cannot fully mimic the natural environment of human organs; the use of animal models leads to several problems, such as ethical concerns, time consumption, and inefficient test results because of the huge differences compared with the human body.[7]

  • When the channel width was wider than 2 mm, it was hard to maintain the shape of the channel

Read more

Summary

Introduction

The microfluidics-based cell culture platform has been revealed as an effective experimental tool for a wide range of biological applications, such as metabolomics,[1] cell analysis,[2,3] and organs-on-chips.[4]. Various types of organs-on-chips have been introduced for simple and precise drug screening in the drug discovery process.[8]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call